- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04852146
Electronic Feedback for Data Restitution and Valorization to the Emergency Teams in Aquitaine. (FERVEUR)
Electronic Feedback for the Restitution and Valorization of Data on the Management of Acute Coronary Syndrome With ST Segment Elevation in Aquitaine to Emergency Teams
ST+ Acute Coronary Syndrome (ACS) is a major cause of mortality, morbidity and healthcare costs in Europe and France. Emergency trans-luminal angioplasty (TLA), the gold standard treatment, is the major determinant of vital prognosis and functional recovery of patients with ST+ ACS.
However, data from surveys and French practice registers highlight frequent deviations from the recommendations at different stages of the procedure; in the pre-hospital phase these malfunctions result in longer delays. Improving the quality of care for patients with ST+ ACS, and in particular improving compliance with recommended delays in the acute phase, is a public health priority in France.
Feedback has been identified as one of the most effective interventions to improve practices and organisations in healthcare institutions. Feedbacks are defined as "any summary of a care performance over a given period of time that can be transmitted a posteriori to the health professional in any form, whether written, oral or by computer (in this case called e-feedbacks)". Feedbacks, by objectifying the level of individual and collective performance, encourage recipients to modify their practices and organisations to improve their performance. It also acts as a social pressure mechanism. While the minimum elements of feedback have been identified in the literature, there is a lack of information about the optimal operational modalities for their deployment, which limits the system's capacity to implement them. To overcome this lack of information, there is a consensus in the scientific community that research on feedback should focus not only on analysing its effectiveness, but above all on the determinants of its effectiveness. With regard to the quality of management of patients with ST+ ACS, only four trials were found in the literature that studied the effectiveness of feedbacks; none of them defined the optimal intervention for deploying feedbacks in the emergency department setting.
Practice registers, particularly in the cardiovascular field, have shown their effectiveness in improving practices, particularly through the implementation of feedback to practitioners, who produce data. In 2012, the ARS Aquitaine set up two regional cardiovascular registers constituting permanent, nominative, continuous and exhaustive records of the management of patients suffering from coronary pathologies: the Aquitaine Interventional Cardiology Register (ACIRA) and the Aquitaine Register of Initial Management of Myocardial Infarction (REANIM). The cross-referencing of the REANIM and ACIRA registers constitutes an exhaustive cohort of patients with ST+ ACS containing information on the management of the entire care pathway, from the onset of symptoms to the end of the hospitalization for the management of the acute episode. This cohort, which is unique in France in the field of coronary pathologies, makes it possible to produce unprecedented and highly accurate information, particularly concerning the time taken to provide care. Wishing to actively engage in a process of changing practices, the Aquitaine Cardiovascular Registries team has developed an e-feedback tool for emergency, EMS and cardiology teams. This tool alone cannot contribute to effectively improving patient care. It is necessary to build an intervention for the deployment of this tool that takes into account the scientific data and the organisational constraints of care. Secondly, the evaluation of the effectiveness and economic impact of this e-feedbacks tool deployment intervention will allow us to know its real added value on practices, organisations and health care expenditure.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study has two phases:
- A phase of construction of the intervention based on qualitative analyses of the focus groups near the professionals of the establishments of the 7 zones SAMU concerned and semi-directive interviews near the directions of the establishments of the 7 zones SAMU concerned;
- A phase of evaluation of the impact of the intervention which is based on a mixed method mixing quantitative and qualitative analyses. The qualitative analyses are based on semi-directive interviews with the professionals concerned in the establishments of the 7 participating UAS zones. The study design of the quantitative part is a cluster randomised controlled trial in a transverse stepped wedge design. The clusters are represented by 7 UAS zones of the ex-Aquitaine region.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Catherine PRADEAU, Dr
- Phone Number: +33 5 57 82 04 14
- Email: catherine.pradeau@chu-bordeaux.fr
Study Locations
-
-
-
Agen, France, 47923
- Centre Hospitalier Agen Nérac
-
Contact:
- Catherine PRADEAU, Dr
- Phone Number: +33 5 57 82 04 14
- Email: catherine.pradeau@chu-bordeaux.fr
-
Bayonne, France, 64100
- Centre Hospitalier de la Cote Basque
-
Contact:
- Catherine PRADEAU, Dr
- Phone Number: +33 5 57 82 04 14
- Email: catherine.pradeau@chu-bordeaux.fr
-
Bordeaux, France, 33000
- Hôpital Pellegrin
-
Contact:
- Catherine PRADEAU, Dr
- Phone Number: +33 5 57 82 04 14
- Email: catherine.pradeau@chu-bordeaux.fr
-
Libourne, France, 33500
- Hôpital de Libourne
-
Contact:
- Catherine PRADEAU, Dr
- Phone Number: +33 5 57 82 04 14
- Email: catherine.pradeau@chu-bordeaux.fr
-
Mont de Marsan, France, 40024
- Centre Hospitalier de Mont de Marsan
-
Contact:
- Catherine PRADEAU, Dr
- Phone Number: +33 5 57 82 04 14
- Email: catherine.pradeau@chu-bordeaux.fr
-
Pau, France, 64000
- Centre Hospitalier de Pau
-
Contact:
- Catherine PRADEAU, Dr
- Phone Number: +33 5 57 82 04 14
- Email: catherine.pradeau@chu-bordeaux.fr
-
Périgueux, France, 24000
- Centre Hospitalier Périgueux
-
Contact:
- Catherine PRADEAU, Dr
- Phone Number: +33 5 57 82 04 14
- Email: catherine.pradeau@chu-bordeaux.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Patient with ST+ ACS, who accept to participate to REANIM or ACIRA registers, and treated by one of the 7 participating emergency zones.
Professional who volunteered to participate in the interviews,from establishments in the 7 participating emergency zones taking care of patients with ST+ ACS in Ex-Aquitaine.
Description
Patient criteria:
Inclusion Criteria:
- Patients over 18 years of age residing in metropolitan France;
- Patients with ST+ ACS less than 24 hours old;
- Patients treated by one of the 19 SMURs (primary and secondary) or one of the 32 emergency services in Aquitaine.
Exclusion Criteria:
- refusal to participate to REANIM or ACIRA registers.
Professional criteria:
Inclusion Criteria:
- Professionals who volunteered to participate in the interviews, from establishments in the 7 participating emergency zones taking care of patients with ST+ ACS in Ex-Aquitaine.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Professional
The sample of professionals will be made up of doctors and nurses of the emergency structures (pre and intra-hospital), doctors and nurses of interventional cardiology and ambulance drivers practising in an establishment of the 7 participating SAMU zones
|
Feedbacks have been identified as one of the most effective interventions to improve practices and organisations in health care institutions.
It is also a tool for facilitating and coordinating practice registers, improving the contribution of data producers and the quality of data.
|
|
Patient
The patient sample will consist of patients included in the REANIM registry during the study period (the entire period of the stepped wedge randomised controlled trial).
|
Feedbacks have been identified as one of the most effective interventions to improve practices and organisations in health care institutions.
It is also a tool for facilitating and coordinating practice registers, improving the contribution of data producers and the quality of data.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessing effectiveness of an e-feedback deployment intervention.
Time Frame: 28 months after the baseline
|
To assess the effectiveness of an e-feedbacks deployment intervention on the proportion of patients with ST+ ACS managed within the recommended time from qualifying ECG to balloon inflation.
|
28 months after the baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Studying acceptability and effectiveness determinants of an e-feedback deployment intervention.
Time Frame: 28 months after the baseline
|
Qualitative analysis of acceptability and effectiveness determinants of an e-feedback deployment intervention in emergency facilities: understanding the implementation contexts, usual professionals behaviours, difficulties encountered in practice, needs and expectations with regard to the intervention.
Thanks to indicivuals interviews.
|
28 months after the baseline
|
|
Evaluate effectiveness of e-feedback deployment intervention
Time Frame: 28 months after the baseline
|
Evaluate effectiveness of e-feedback deployment intervention, thanks to the time between qualifying ECG and balloon inflation
|
28 months after the baseline
|
|
Economic assessment
Time Frame: 28 months after the baseline
|
Total cost (in €) of production (design, implementation) of the electronic feedback intervention, thanks to micro-costing
|
28 months after the baseline
|
|
Assessment of health care consumption
Time Frame: 28 months after the baseline
|
Difference in health care consumption between the period with and without the intervention and typology of health care consumption between the groups based on SNDS data.
|
28 months after the baseline
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Florence SAILLOUR-GLENISSON, Dr, UMES
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CHUBX 2019/64
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Coronary Syndrome
-
Chulalongkorn UniversityCompletedCKD | Coronary Angiography (CAG) | ACS (Acute Coronary Syndrome)
-
Shenyang Northern HospitalNot yet recruitingSGLT2 Inhibitors | ACS (Acute Coronary Syndrome)China
-
Mahidol UniversityNot yet recruitingCoronary Artery Disease | Acute Coronary Syndrome/ Myocardial InfarctionThailand
-
Aarhus University Hospital SkejbyAbbottEnrolling by invitationIschemic Heart Disease | Ischemic Coronary Artery Disease | ACS (Acute Coronary Syndrome)Denmark, Belgium, Germany, Finland, Sweden, Switzerland, Latvia, Norway, United Kingdom, Estonia, Netherlands, Italy
-
Samsung Medical CenterNot yet recruitingCoronary Artery Disease | Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
-
Heart Care FoundationNovartis Farma S.p.A.Not yet recruitingAcute Coronary Syndromes | Chronic Coronary SyndromesItaly
-
Yonsei UniversityRecruitingCoronary Artery Disease, Acute Coronary SyndromeKorea, Republic of
-
University of GalwayNot yet recruitingMyocardial Ischemia | Percutaneous Coronary Intervention | Chronic Coronary Syndrome | Coronary Computed Tomography Angiography | Acute Coronary Syndromes (ACS) | Coronary Arteries Disease
-
Xiling QiRecruitingHF - Heart Failure | ACS (Acute Coronary Syndrome)China
-
Tongji HospitalRecruiting
Clinical Trials on Electronic feedback
-
University of AarhusCompleted
-
Centre Hospitalier Universitaire de BesanconUniversity of Franche-Comté; University of BurgundyRecruitingLung Cancer | Non Small Cell Lung CancerFrance
-
Tine De BurghraeveWithdrawnHeart Failure | Diabetes Mellitus | Chronic Kidney Diseases
-
The Miriam HospitalUniversity of Tennessee; Weight Watchers InternationalCompleted
-
Southern Medical University, ChinaNot yet recruiting
-
Children's Hospital of PhiladelphiaUniversity of Pennsylvania; National Heart, Lung, and Blood Institute (NHLBI); Boston Children's Hospital and other collaboratorsActive, not recruiting
-
University of Wisconsin, MadisonCompletedBreast CancerUnited States
-
Boston UniversityBeijing Ditan Hospital; Second People's Hospital, DaliCompleted
-
Children's National Research InstituteRecruitingPain | Fractures, Bone | Appendicitis | Bias, RacialUnited States
-
UConn HealthAgency for Healthcare Research and Quality (AHRQ)Completed